The advent of the IHC technique makes it possible to identify the neuroendocrine phenotypes in breast cancer subpopulations by displaying their immunoreactivity to CgA, Syn, neuron-specific enolase (NSE), and CD56, which are usually negative in IBC-NSTs. The gene discussed is CGA; the disease is breast carcinoma.